Bone Health During GLP-1 Treatment Estrogen plays a protective role in maintaining bone mineral density, and both menopause and rapid weight loss can reduce bone density
3,4,5 There are currently 3 FDA-approved medications for the indication of weight loss, with the most recent being tirzepatide (Zepbound
Indeed, studies often focus on MCFAs or MCTs which are present in both oils but in different proportions, making it challenging to draw precise conclusions about the superior advantages of MCT oil
As GLP-1 utilization expanded, new patient volume for hypertension and high cholesterol therapies declined, with 2024 marking the steepest drop, 3% for hypertension and 4% for high cholesterol
Researchers often study how these pathways may interact and influence broader metabolic systems
doi: 10.1016/j.brainres.2012.07.029 168 ParthsarathyVHolscherC